Bayesian Uncertainty Directed Trial Designs

References

• Barker, A., Sigman, C., Kelloff, G., Hylton, N., Berry, D., and Esserman, L. (2009), “I-SPY 2: An Adaptive Breast Cancer Trial Design in the Setting of Neoadjuvant Chemotherapy,” Clinical Pharmacology & Therapeutics, 86, 97–100.
   PubMed Web of Science ®Google Scholar
• Berger, J. (1985), Statistical Decision Theory and Bayesian Analysis, New York: Springer.
   Google Scholar
• Berry, D. A. (1987), “Interim Analysis in Clinical Trials: The Role of the Likelihood Principle,” The American Statistician, 41, 117–122.
   Web of Science ®Google Scholar
• Berry, D. A., and Eick, S. G. (1995), “Adaptive Assignment Versus Balanced Randomization in Clinical Trials: A Decision Analysis,” Statistics in Medicine, 14, 231–246.
   PubMed Web of Science ®Google Scholar
• Berry, D. A., and Fristedt, B. (1985), Bandit Problems: Sequential Allocation of Experiments, New York: Springer.
   Google Scholar
• Berry, D. A., and Ho, C.-H. (1988), “One-Sided Sequential Stopping Boundaries for Clinical Trials: A Decision-Theoretic Approach,” Biometrics, 44, 219–227.
   PubMed Web of Science ®Google Scholar
• Berry, S. M., Carlin, B. P., Lee, J. J., and Muller, P. (2010), Bayesian Adaptive Methods for Clinical Trials, Boca Raton, FL: CRC Press.
   Google Scholar
• Berry, S. M., and Kadane, J. B. (1997), “Optimal Bayesian Randomization,” Journal of the Royal Statistical Society, Series B, 59, 813–819.
   Google Scholar
• Brockwell, A. E., and Kadane, J. B. (2003), “A Gridding Method for Bayesian Sequential Decision Problems,” Journal of Computational and Graphical Statistics, 12, 566–584.
   Web of Science ®Google Scholar
• Bubeck, S., and Cesa-Bianchi, N. (2012), “Regret Analysis of Stochastic and Nonstochastic Multi-Armed Bandit Problems,” Foundations and Trends® in Machine Learning, 5, 1–122.
   Google Scholar
• Carlin, B. P., Kadane, J. B., and Gelfand, A. E. (1998), “Approaches for Optimal Sequential Decision Analysis in Clinical Trials,” Biometrics, 54, 964–975.
   PubMed Web of Science ®Google Scholar
• Cellamare, M., Milstein, M., Ventz, S., Baudin, E., Trippa, L., and Mitnick, C. (2016), “Bayesian Adaptive Randomization in a Clinical Trial to Identify New Regimens for MDR-TB: The endTB Trial,” The International Journal of Tuberculosis and Lung Disease, 20, S8–S12.
   PubMed Web of Science ®Google Scholar
• Cheng, Y., and Berry, D. A. (2007), “Optimal Adaptive Randomized Designs for Clinical Trials,” Biometrika, 94, 673–689.
   Web of Science ®Google Scholar
• Druss, B. G., Rohrbaugh, R. M., Levinson, C. M., and Rosenheck, R. A. (2001), “Integrated Medical Care for Patients with Serious Psychiatric Illness: A Randomized Trial,” Archives of General Psychiatry, 58, 861–868.
   PubMed Web of Science ®Google Scholar
• Hu, F., and Rosenberger, W. F. (2006), The theory of Response-Adaptive Randomization in Clinical Trials, New York: Wiley.
   Google Scholar
• Jennison, C., and Turnbull, B. W. (1999), Group Sequential Methods with Applications to Clinical Trials, Boca Raton, FL: CRC Press.
   Google Scholar
• Jung, S.-H., Lee, T., Kim, K., and George, S. L. (2004), “Admissible Two-Stage Designs for Phase II Cancer Clinical Trials,” Statistics in Medicine, 23, 561–569.
   PubMed Web of Science ®Google Scholar
• Kadane, J. B., and Vlachos, P. K. (2002), “Hybrid Methods for Calculating Optimal Few-Stage Sequential Strategies: Data Monitoring for a Clinical Trial,” Statistics and Computing, 12, 147–152.
   Web of Science ®Google Scholar
• Kim, E. S., Herbst, R. S., Wistuba, I. I., Lee, J. J., Blumenschein, G. R., Tsao, A., Stewart, D. J., Hicks, M. E., Erasmus, J., Gupta, S., Alden, S. L., Tang, X., Khuri, F. R., Tran, H. T., Johnson, B. E., Heymach, J. V., Mao, L., Fossella, F., Kies, M. S., Papadimitrakopoulou, V., Davis, S. E., Lippman, S. M., and Hong, W. K. (2011), “The BATTLE Trial: Personalizing Therapy for Lung Cancer,” Cancer Discovery, 1, 44–53.
   PubMed Web of Science ®Google Scholar
• Korn, E. L., and Freidlin, B. (2011), “Outcome-Adaptive Randomizations: Is It Useful?” Journal of Clinical Oncology, 29, 771–776.
   PubMed Web of Science ®Google Scholar
• Lee, J. J., Gu, X., and Liu, S. (2010), “Bayesian Adaptive Randomization Designs for Targeted Agent Development,” Clinical Trials, 7, 584–596.
   PubMed Web of Science ®Google Scholar
• Lenca, P., Lallich, S., and Vaillant, B. (2010), “Construction of an off-Centered Entropy for the Supervised Learning of Imbalanced Classes: Some First Results,” Communications in Statistics—Theory and Methods, 39, 493–507.
   Web of Science ®Google Scholar
• Lewis, R. J., and Berry, D. A. (1994), “Group Sequential Clinical Trials: A Classical Evaluation of Bayesian Decision-Theoretic Designs,” Journal of the American Statistical Association, 89, 1528–1534.
   Web of Science ®Google Scholar
• Müller, P., Berry, D. A., Grieve, A. P., Smith, M., and Krams, M. (2007), “Simulation-Based Sequential Bayesian Design,” Journal of Statistical Planning and Inference, 137, 3140–3150.
   Web of Science ®Google Scholar
• Offen, W., Chuang-Stein, C., Dmitrienko, A., Littman, G., Maca, J., Meyerson, L., Muirhead, R., Stryszak, P., Baddy, A., Chen, K., Copley-Merriman, K., Dere, W., Givens, S., Hall, D., Henry, D., Jackson, J. D., Krishen, A., Liu, T., Ryder, S., Sankoh, A. J., Wang, J., and Yeh, C.-H. (2007), “Multiple Co-primary Endpoints: Medical and Statistical Solutions: A Report from the Multiple Endpoints Expert Team of the Pharmaceutical Research and Manufacturers of America,” Drug Information Journal, 41, 31–46.
   Web of Science ®Google Scholar
• Pemantle, R. (2007), “A survey of Random Processes with Reinforcement,” Probability Surveys, 4, 1–79.
   Google Scholar
• Polivka, J., and Janku, F. (2014), “Molecular Targets for Cancer Therapy in the PI3K/AKT/mTOR Pathway,” Pharmacology & Therapeutics, 142, 164–175.
   PubMed Web of Science ®Google Scholar
• Russo, D., and Van Roy, B. (2014), “Learning to Optimize via Information-Directed Sampling,” in Advances in Neural Information Processing Systems, eds. Z. Ghahramani, M. Welling, C. Cortes, N. D. Lawrence, and K. Q. Weinberger, pp. 1583–1591.
   Google Scholar
• Schöffski, P., Riggert, S., Fumoleau, P., Campone, M., Bolte, O., Marreaud, S., Lacombe, D., Baron, B., Herold, M., Zwierzina, H., Wilhelm-Ogunbiyi, K., Lentzen, H., and Twelves, C. (2004), “Phase I Trial of Intravenous Aviscumine (rViscumin) in Patients with Solid Tumors: A Study of the European Organization for Research and Treatment of Cancer New Drug Development Group,” Annals of Oncology, 15, 1816–1824.
   PubMed Web of Science ®Google Scholar
• Stallard, N., and Friede, T. (2008), “A Group-Sequential Design for Clinical Trials with Treatment Selection,” Statistics in Medicine, 27, 6209–6227.
   PubMed Web of Science ®Google Scholar
• Teixeira-Pinto, A., Siddique, J., Gibbons, R., and Normand, S. L. (2009), “Statistical Approaches to Modeling Multiple Outcomes in Psychiatric Studies,” Psychiatric Annals, 39, 729–735.
   PubMed Web of Science ®Google Scholar
• Thall, P., Fox, P., and Wathen, J. (2015), “Statistical Controversies in Clinical Research: Scientific and Ethical Problems with Adaptive Randomization in Comparative Clinical Trials,” Annals of Oncology, 26, 1621–1628.
   PubMed Web of Science ®Google Scholar
• Thall, P. F. (2010), “Bayesian Models and Decision Algorithms for Complex Early Phase Clinical Trials,” Statistical Science, 25, 227–244.
   PubMed Web of Science ®Google Scholar
• Thall, P. F., Simon, R. M., and Estey, E. H. (1995), “Bayesian Sequential Monitoring Designs for Single-Arm Clinical Trials with Multiple Outcomes,” Statistics in Medicine, 14, 357–379.
   PubMed Web of Science ®Google Scholar
• Thall, P. F., and Wathen, J. K. (2007), “Practical Bayesian Adaptive Randomisation in Clinical Trials,” European Journal of Cancer, 43, 859–866.
   PubMed Web of Science ®Google Scholar
• Thompson, W. R. (1933), “On the Likelihood that One Unknown Probability Exceeds Another in View of the Evidence of Two Samples,” Biometrika, 25, 285–294.
   Google Scholar
• Trippa, L., and Alexander, B. M. (2017), “Bayesian Baskets: A Novel Design for Biomarker-Based Clinical Trials,” Journal of Clinical Oncology, 35, 681–687.
   PubMed Web of Science ®Google Scholar
• Trippa, L., Lee, E. Q., Wen, P. Y., Batchelor, T. T., Cloughesy, T., Parmigiani, G., and Alexander, B. M. (2012), “Bayesian Adaptive Randomized Trial Design for Patients with Recurrent Glioblastoma,” Journal of Clinical Oncology, 30, 3258–3263.
   PubMed Web of Science ®Google Scholar
• Ventz, S., Barry, W. T., Parmigiani, G., and Trippa, L. (2017a), “Bayesian Response-Adaptive Designs for Basket Trials,” Biometrics, 73, 905–915.
   PubMed Web of Science ®Google Scholar
• Ventz, S., Parmigiani, G., and Trippa, L. (2017b), “Combining Bayesian Experimental Designs and Frequentist Data Analyses: Motivations and Examples,” Applied Stochastic Models in Business and Industry, 33, 302–313.
   Web of Science ®Google Scholar
• Ventz, S., and Trippa, L. (2015), “Bayesian Designs and the Control of Frequentist Characteristics: A Practical Solution,” Biometrics, 71, 218–226.
   PubMed Web of Science ®Google Scholar
• Wason, J., and Jaki, T. (2012), “Optimal Design of Multi-Arm Multi-Stage Trials,” Statistics in Medicine, 31, 4269–4279.
   PubMed Web of Science ®Google Scholar
• Wei, L. (1979), “The Generalized Polya’s urn Design for Sequential Medical Trials,” The Annals of Statistics, 7, 291–296.
   Web of Science ®Google Scholar
• Xu, Y., Trippa, L., Müller, P., and Ji, Y. (2016), “Subgroup-Based Adaptive (SUBA) Designs for Multi-Arm Biomarker Trials,” Statistics in Biosciences, 8, 159–180.
   PubMed Web of Science ®Google Scholar
• Zhang, Y., Trippa, L., and Parmigiani, G. (2016), “Optimal Bayesian Adaptive Trials when Treatment Efficacy Depends on Biomarkers,” Biometrics, 72, 414–421.
   PubMed Web of Science ®Google Scholar